首页> 美国卫生研究院文献>OncoTargets and therapy >Evaluation of the UK Myeloma Research Alliance Risk Profile in Chinese Patients with Newly Diagnosed Multiple Myeloma without Autologous Stem Cell Transplantation

【2h】

Evaluation of the UK Myeloma Research Alliance Risk Profile in Chinese Patients with Newly Diagnosed Multiple Myeloma without Autologous Stem Cell Transplantation

机译：评估英国骨髓瘤研究联盟风险危险性危险性危险性新诊断的多发性骨髓瘤没有自体干细胞移植

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

期刊名称 OncoTargets and therapy
作者
Kewa Ma; Jiannan Ye; Lingling Wang; Chao Sun; Xin Zhou;
展开▼
作者单位

展开▼
年(卷),期 2021(-1),-1
年度 2021
页码 -1
总页数 13
原文格式 PDF
正文语种
中图分类应用微生物学;肿瘤学;
关键词
multiple myeloma; myeloma risk profile; bortezomib; complex chromosome karyotype; prognosis;

机译：多发性骨髓瘤;骨髓瘤风险概况;Bortezomib;复杂染色体核型;预后;

相似文献

外文文献
中文文献
专利

1. Validation of the UK myeloma research alliance risk profile, a new clinical prediction model for outcome in patients with newly diagnosed multiple myeloma not eligible for autologous stem cell transplantation; a population-based study from the Danish national multiple myeloma registry [J] . Redder Louise, Klausen Tobias W., Vangsted Annette Juul, British Journal of Haematology . 2021,第1期

机译：验证英国骨髓瘤研究联盟风险概况，新诊断的多发性骨髓瘤患者患者的新临床预测模型，没有资格获得自体干细胞移植; 丹麦国家多骨髓瘤登记处的基于人口的研究
2. Survival Analysis from the CALGB Study of Lenalidomide Maintenance Therapy in Newly Diagnosed Multiple Myeloma Post-Autologous Stem Cell Transplantation Adjusted for Crossover (Alliance 100104) [J] . McCarthy Philip L., Richardson Paul, Suman Vera, Blood: The Journal of the American Society of Hematology . 2018,第NovaelaTreatmentAppr期

机译：基因多元维持治疗的CALGB研究的生存分析在新诊断的多发性骨髓瘤后自体干细胞移植进行交叉（联盟100104）
3. High-Dose Chemotherapy with Early Autologous Stem Cell Transplantation Compared to Standard Dose Chemotherapy or Delayed Transplantation in Patients with Newly Diagnosed Multiple Myeloma: A Systematic Review and Meta-Analysis [J] . Jain Tania, Sonbol Mohamad Bassam, Firwana Belal, Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation . 2019,第2期

机译：None
4. Reconstitution of B Lineage Cells After Auto- PBSCT in Patients with Multiple Myeloma [C] . M. Feliksbrot, M.A. Krol, J. Dwilewicz-Trojaczek European Haematology Association . 2002

机译：多发性骨髓瘤患者自身PBSCT后重建B谱系细胞
5. Natural Killer Cell Recovery and Disease Outcomes After Autologous Stem Cell Transplantation in Multiple Myeloma [D] . Keruakous, Amany R. 2021

机译：自然杀手细胞回收和疾病结果在多发性骨髓瘤中的自体干细胞移植后
6. Prognostic Significance of Blood Transfusion in Newly Diagnosed Multiple Myeloma Patients without Autologous Hematopoietic Stem Cell Transplantation [O] . Liping Fan, Danhui Fu, Jinping Zhang, 2006

机译：新诊断的无自体造血干细胞移植的多发性骨髓瘤患者的输血预后意义
7. High efficacy and safety of VTD as an induction protocol in patients with newly diagnosed multiple myeloma eligible for high dose therapy and autologous stem cell transplantation: A report of the Polish Myeloma Study Group [O] . Iwona Hus, Joanna Mańko, Dariusz Jawniak, 2019

机译：VTD的高疗效和安全性作为新诊断的多发性骨髓瘤患者的诱导方案，符合高剂量治疗和自体干细胞移植的患者：波兰骨髓瘤研究组的报告

Evaluation of the UK Myeloma Research Alliance Risk Profile in Chinese Patients with Newly Diagnosed Multiple Myeloma without Autologous Stem Cell Transplantation

著录项

相似文献

相关主题

期刊订阅